CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-06 | Boxer Capital, LLC See Remarks | Grant or award | +63,412 | $13.01 | $825K | 85,939 |
| 2024-02-06 | Boxer Capital, LLC See Remarks | Grant or award · Warrant (right to purchase) | +705,280 | $13.01 | $9.2M | 705,280 |
| 2021-12-17 | Boxer Capital, LLC 10% owner | Purchase | +125,000 | $13.12 | $1.6M | 6,448,359 |
| 2021-09-17 | Boxer Capital, LLC 10% owner | Conversion | +5,698,359 | 5,698,359 | ||
| 2021-09-17 | Boxer Capital, LLC 10% owner | Purchase | +625,000 | $16.00 | $10.0M | 6,323,359 |
| 2021-09-17 | Boxer Capital, LLC 10% owner | Conversion | +288,095 | 288,095 | ||
| 2021-09-17 | Boxer Capital, LLC 10% owner | Conversion · Series A Preferred Stock | −1,480,242 | 0 | ||
| 2021-09-17 | Boxer Capital, LLC 10% owner | Conversion · Series A Preferred Stock | −95,516 | 0 | ||
| 2021-09-17 | Boxer Capital, LLC 10% owner | Conversion · Series B Preferred Stock | −713,629 | 0 | ||
| 2021-09-17 | Boxer Capital, LLC 10% owner | Conversion · Series B Preferred Stock | −15,401 | 0 |
Page 1 of 1 · 10 trades